Table 2.
Author, Year | ncRNA | Expression | Direct Targets (Indirectly Affected Genes) | Cell Type |
---|---|---|---|---|
Immune cells | ||||
Zheng et al., 2017 [126] | miR-143 | Down | BCL2 | PBMCs |
Fu et al., 2015 [125] | miR-138 | Down | RUNX3 | CD4+ T cells |
Garcıa–Rodrıguez et al., 2016 [128] | miR-146a | Up | TRAF6, IRAK1, (NF-κΒ, IL-6, TNFα) | PBMCs |
Garcıa–Rodrıguez et al., 2016 [128] | miR-21 | Up | PDCD4 | PBMCs |
Garcıa–Rodrıguez et al., 2016 [128] | miR-155 | Up | SOCS1 | PBMCs |
Serum levels | ||||
Duan et al., 2019 [130] | miR-126 | Down | - | Plasma |
Ichihara et al., 2011 [106] | miR-424 | Down | (MEK1, CCNE1) | Plasma |
Zhao et al., 2014 [129] | miR-210 | Up | FOXP3, (IFN-γ, IL-17, IL-10, TGF-β) | Plasma |
Magenta et al., 2019 [109] | miR-200c | Up | SIRT1, eNOS, FOXO1 | Plasma |
Wang et al., 2017 [131] | miR-200a | Up | - | Plasma |
Borska et al., 2017 [132] | miR-31 | Up | - | Plasma |
García-Rodríguez et al., 2014 [133] | miR-33 | Up | ABCA1 | Plasma |
Guo et al., 2013 [134] | miR-369-3p | Up | - | Plasma |
Abbreviations: ncRNA, non-coding RNA; miR, microRNA; PBMCs, peripheral blood mononuclear cells.